← FDA Drug Approvals (Drugs@FDA)

NYSTATIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ZYDUS PHARMS · Approved 2017-06-08

Drug application

FDA Application #

ANDA208581

Application type

Abbreviated New Drug Application (Generic)

Brand name

NYSTATIN

Generic name

NYSTATIN

Active ingredients

NYSTATIN

Dosage form

POWDER

Route

TOPICAL

Marketing status

Prescription

Sponsor

ZYDUS PHARMS

Manufacturer

Zydus Lifesciences Limited

First approval

2017-06-08

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown